PharVision Advisers’s Paylocity PCTY Stock Holding History

PharVision Advisers’s Portfolio PCTY Stock Details PCTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,441	Closed	-$389K	–	926
2025 Q3	$389K	Buy	+2,441	New	+$432K	0.22%	92

Other funds holding PCTY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's PCTY Position: Q4 2025 in Review

PharVision Advisers sold out of Paylocity (PCTY) in Q4 2025, closing a stake of 2,441 shares — an estimated $389K sold.

PharVision Advisers first reported a position in PCTY in Q3 2025 and held it in 1 quarter. The position peaked at $389K in Q3 2025. 463 funds tracked by Wall St. Rank hold PCTY as of Q4 2025.

PharVision Advisers reported no remaining Paylocity position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,441 Paylocity shares in Q4 2025, an estimated $389K.
PharVision Advisers first reported a position in Paylocity in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Paylocity position peaked at $389K in Q3 2025.
463 funds tracked by Wall St. Rank held Paylocity as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.